J. Greengard

发表

Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vector.

D. Jolly, J. McCormack, W. Edwards, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD

S. Kiss, M. Gasmi, J. Greengard, 2020, Molecular therapy. Methods & clinical development.

Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration

Pallavi Sharma, S. Kiss, M. Lawrence, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Engineering goals for future thoracic endografts-how can we make them more effective?

S. Zannetti, J. Greengard, K. Boyle, 2013, Progress in cardiovascular diseases.

Retroviral activation of interleukin 2 gene in a gibbon ape T cell lymphoma line

G. Crabtree, N. Holbrook, J. Kant, 1986, The Journal of experimental medicine.

Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.

S. Chang, P. Sheridan, T. Dubensky, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates

Pallavi Sharma, S. Kiss, M. Gasmi, 2021, Translational vision science & technology.

The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent

T. Dubensky, A. Watt, K. Murthy, 1999, Journal of Virology.

Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema

Pallavi Sharma, S. Kiss, M. Gasmi, 2021, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Analysis of testes and semen from rabbits treated by intravenous injection with a retroviral vector encoding the human factor VIII gene: no evidence of germ line transduction.

K. Boekelheide, M. Giedlin, D. Johnson, 2000, Human gene therapy.

ZFN-Mediated Gene Targeting at the Albumin Locus in Liver Results in Therapeutic Levels of Human FIX in Mice and Non-Human Primates

Yolanda Santiago, David E. Paschon, E. Rebar, 2015 .

A viral long terminal repeat in the interleukin 2 gene of a cell line that constitutively produces interleukin 2.

G. Crabtree, N. Holbrook, Y. Lin, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Animal Testing of Retroviral-Mediated Gene Therapy for Factor VIII Deficiency

D. Jolly, J. Greengard, J. Greengard, 1999, Thrombosis and Haemostasis.

Engineering goals for future thoracic endografts-how can we make them more effective?

S. Zannetti, J. Greengard, K. Boyle, 2013, Progress in cardiovascular diseases.